{
  "responseStatus": 200,
  "responseDetails": null,
  "responseData": {
    "feed": {
      "feedUrl": "http://investors.amgen.com/rss/news-releases.xml",
      "title": "Amgen Inc. News Releases",
      "link": "http://investors.amgen.com/",
      "description": "Amgen Inc. News Releases",
      "author": "",
      "entries": [
        {
          "title": "Nplate® (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia",
          "link": "http://investors.amgen.com/news-releases/news-release-details/nplater-romiplostim-now-approved-earlier-use-adults-immune",
          "content": "32% of Patients Achieved Treatment-Free Remission for at Least Six Months in a Single-Arm Trial 93% of Patients Achieved a Platelet Response THOUSAND OAKS, Calif. , Oct. 18, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration ( FDA ) approved Amgen's",
          "contentSnippet": "32% of Patients Achieved Treatment-Free Remission for at Least Six Months in a Single-Arm Trial 93% of Patients Achieved",
          "publishedDate": "2019-10-18T13:00:00.000Z",
          "categories": [],
          "author": "Amgen Inc. News Releases"
        },
        {
          "title": "EVENITY® (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture",
          "link": "http://investors.amgen.com/news-releases/news-release-details/evenityr-romosozumab-receives-positive-chmp-opinion-treatment",
          "content": "THOUSAND OAKS, Calif. and BRUSSELS , Oct. 17, 2019 /PRNewswire/ --  Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced that following a re-examination procedure, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive",
          "contentSnippet": "THOUSAND OAKS, Calif. and BRUSSELS , Oct. 17, 2019 /PRNewswire/ --  Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB)",
          "publishedDate": "2019-10-18T05:00:00.000Z",
          "categories": [],
          "author": "Amgen Inc. News Releases"
        },
        {
          "title": "Sports Anchor And Multiple Myeloma Patient Rod Gilmore Joins Amgen's Myeloma MVP™ Team",
          "link": "http://investors.amgen.com/news-releases/news-release-details/sports-anchor-and-multiple-myeloma-patient-rod-gilmore-joins",
          "content": "Updated Tool for 2019 Helps Patients Create Their Most Valuable Plan for Managing Multiple Myeloma Gilmore Joins Baseball Hall of Famer Dave Winfield and Don Baylor Jr. Who Honor the Late Don Baylor's Legacy by Raising Awareness of Multiple Myeloma THOUSAND OAKS, Calif. , Oct.",
          "contentSnippet": "Updated Tool for 2019 Helps Patients Create Their Most Valuable Plan for Managing Multiple Myeloma Gilmore Joins Basebal",
          "publishedDate": "2019-10-15T13:00:00.000Z",
          "categories": [],
          "author": "Amgen Inc. News Releases"
        }
      ]
    }
  }
}